US Patent

US7811254 — Autoinjector with needle depth adapter

Method of Use · Assigned to Meridian Medical Technologies Inc · Expires 2027-08-26 · 1y remaining

Vulnerability score 63/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects an autoinjector with a needle depth adapter for achieving a desired injection depth.

USPTO Abstract

An autoinjector useful for, inter alia, providing an injection of liquid medicament is disclosed, which includes a needle depth adapter for achieving a desired injection depth.

Drugs covered by this patent

sumatriptan-succinate (SUMATRIPTAN SUCCINATE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-1083`	—	sumatriptan-succinate

Patent Metadata

Patent number: US7811254
Jurisdiction: US
Classification: Method of Use
Expires: 2027-08-26
Drug substance claim: No
Drug product claim: Yes
Assignee: Meridian Medical Technologies Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.